JW (CAYMAN) THERAPEUTICS CO. LTD earnings per share and revenue

2126 earnings per share for the last semiannual are -1.03 HKD whereas the estimation was -0.89 HKD which accounts for -16.05% surprise. Company revenue for the same period amounts to 94.68 M HKD despite the estimated figure of 106.18 M HKD. Estimated earnings per share for the next semiannual are -0.69 HKD, and revenue is expected to reach 116.38 M HKD. Also watch annual changes over time to get a bigger picture of 2126 earnings per share and revenue dynamics.